116 related articles for article (PubMed ID: 17149877)
21. Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro.
Huang J; Yuan L; Wang X; Zhang TL; Wang K
Life Sci; 2007 Aug; 81(10):832-40. PubMed ID: 17764702
[TBL] [Abstract][Full Text] [Related]
22. Cathepsin K inhibitors: a novel target for osteoporosis therapy.
Stoch SA; Wagner JA
Clin Pharmacol Ther; 2008 Jan; 83(1):172-6. PubMed ID: 18073778
[TBL] [Abstract][Full Text] [Related]
23. Pseudomonas aeruginosa lipopolysaccharide induces osteoclastogenesis through a toll-like receptor 4 mediated pathway in vitro and in vivo.
Zhuang L; Jung JY; Wang EW; Houlihan P; Ramos L; Pashia M; Chole RA
Laryngoscope; 2007 May; 117(5):841-7. PubMed ID: 17473680
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of osteoblastic metalloproteinases in mice prevents bone loss induced by oestrogen deficiency.
Schiltz C; Marty C; de Vernejoul MC; Geoffroy V
J Cell Biochem; 2008 Aug; 104(5):1803-17. PubMed ID: 18384129
[TBL] [Abstract][Full Text] [Related]
25. Amino derivatives of phenyl alkyl thiophene as inhibitors of bone resorption. Structure-activity relationship.
Wierzbicki M; Boussard MF; Sauveur F; Kirsch G; Sabatini M; Lesur C; Trodjman C; Bonnet J
Arzneimittelforschung; 1998 Aug; 48(8):840-9. PubMed ID: 9748714
[TBL] [Abstract][Full Text] [Related]
26. Phosphonocarboxylate inhibitors of Rab geranylgeranyl transferase disrupt the prenylation and membrane localization of Rab proteins in osteoclasts in vitro and in vivo.
Coxon FP; Ebetino FH; Mules EH; Seabra MC; McKenna CE; Rogers MJ
Bone; 2005 Sep; 37(3):349-58. PubMed ID: 16006204
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of heterocyclic ring-fused betulinic acid derivatives as novel inhibitors of osteoclast differentiation and bone resorption.
Xu J; Li Z; Luo J; Yang F; Liu T; Liu M; Qiu WW; Tang J
J Med Chem; 2012 Apr; 55(7):3122-34. PubMed ID: 22435650
[TBL] [Abstract][Full Text] [Related]
28. Naringenin inhibits human osteoclastogenesis and osteoclastic bone resorption.
La VD; Tanabe S; Grenier D
J Periodontal Res; 2009 Apr; 44(2):193-8. PubMed ID: 18705650
[TBL] [Abstract][Full Text] [Related]
29. Extracts of marine algae show inhibitory activity against osteoclast differentiation.
Koyama T
Adv Food Nutr Res; 2011; 64():443-54. PubMed ID: 22054967
[TBL] [Abstract][Full Text] [Related]
30. Effect of novel N-cyano-tetrahydro-pyridazine compounds, a class of cathepsin K inhibitors, on the bone resorptive activity of mature osteoclasts.
Kim SH; Jhon DJ; Song JH; No JS; Kang NS
Bioorg Med Chem Lett; 2008 Jul; 18(14):3988-91. PubMed ID: 18571402
[TBL] [Abstract][Full Text] [Related]
31. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro.
Bonnelye E; Chabadel A; Saltel F; Jurdic P
Bone; 2008 Jan; 42(1):129-38. PubMed ID: 17945546
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, properties, and perspectives of gem-diphosphono substituted-thiazoles.
Abdou WM; Ganoub NA; Geronikaki A; Sabry E
Eur J Med Chem; 2008 May; 43(5):1015-24. PubMed ID: 17870210
[TBL] [Abstract][Full Text] [Related]
33. Ostreae Testa prevent ovariectomy-induced bone loss in mice by osteoblast activations.
Han SY; Lee JR; Kwon YK; Jo MJ; Park SJ; Kim SC; Lee HS; Ku SK
J Ethnopharmacol; 2007 Dec; 114(3):400-5. PubMed ID: 17905549
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
[TBL] [Abstract][Full Text] [Related]
35. Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resorptive activity in clinically relevant conditions.
Boissy P; Andersen TL; Lund T; Kupisiewicz K; Plesner T; Delaissé JM
Leuk Res; 2008 Nov; 32(11):1661-8. PubMed ID: 18394701
[TBL] [Abstract][Full Text] [Related]
36. Increased circulating heat shock protein 60 induced by menopause, stimulates apoptosis of osteoblast-lineage cells via up-regulation of toll-like receptors.
Kim YS; Koh JM; Lee YS; Kim BJ; Lee SH; Lee KU; Kim GS
Bone; 2009 Jul; 45(1):68-76. PubMed ID: 19306954
[TBL] [Abstract][Full Text] [Related]
37. Quantitative and reliable in vitro method combining scanning electron microscopy and image analysis for the screening of osteotropic modulators.
Grimandi G; Soueidan A; Anjrini AA; Badran Z; Pilet P; Daculsi G; Faucheux C; Bouler JM; Guicheux J
Microsc Res Tech; 2006 Aug; 69(8):606-12. PubMed ID: 16718652
[TBL] [Abstract][Full Text] [Related]
38. Heat shock protein 60 causes osteoclastic bone resorption via toll-like receptor-2 in estrogen deficiency.
Koh JM; Lee YS; Kim YS; Park SH; Lee SH; Kim HH; Lee MS; Lee KU; Kim GS
Bone; 2009 Oct; 45(4):650-60. PubMed ID: 19527807
[TBL] [Abstract][Full Text] [Related]
39. Novel bromomelatonin derivatives as potentially effective drugs to treat bone diseases.
Suzuki N; Somei M; Seki A; Reiter RJ; Hattori A
J Pineal Res; 2008 Oct; 45(3):229-34. PubMed ID: 18691356
[TBL] [Abstract][Full Text] [Related]
40. Discovery of coumarin-dihydropyridine hybrids as bone anabolic agents.
Sashidhara KV; Kumar M; Khedgikar V; Kushwaha P; Modukuri RK; Kumar A; Gautam J; Singh D; Sridhar B; Trivedi R
J Med Chem; 2013 Jan; 56(1):109-22. PubMed ID: 23214410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
